tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Beuchaw, 49 are a HOLD (36.57%), 30 are a SELL (22.39%), 55 are a BUY (41.04%).
Analyst Steve Beuchaw, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 72.67% that have a potential upside of 20.89% achieved within 335 days. Previously, Steve Beuchaw worked at MORGAN STANLEY, WOLFE.
Steve Beuchaw’s has documented 255 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QGEN, Qiagen NV at 04-Aug-2024.
Analyst best performing recommendations are on ALGN (ALIGN TECHNOLOGY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 10/9/2018. The price target of $320 was fulfilled within 1 day with a profit of $20.97 (6.15%) receiving and performance score of 61.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Feb-2021
$155
$14.35 (10.20%)
$220
Buy Since 13-Feb-2025
$209
$68.35 (48.60%)
$200
2 months 29 days ago
(08-Jul-2026)
1/6 (16.67%)
$30.83 (17.30%)
99
Buy Since 17-Oct-2013
$210
$69.35 (49.31%)
4 months 20 days ago
(17-May-2026)
46/72 (63.89%)
$51.22 (32.26%)
145
Hold Since 21-Oct-2025
$188
$9.57 (5.36%)
$169
5 months 13 days ago
(24-Apr-2026)
26/40 (65%)
$-1.61 (-0.85%)
128
Buy Since 01-May-2025
$235
$56.57 (31.70%)
$220
5 months 16 days ago
(21-Apr-2026)
18/53 (33.96%)
$39.8 (20.39%)
101
What Year was the first public recommendation made by Steve Beuchaw?
